Overview
Pharmbiopol is a contract manufacturer specializing in dietary supplements, cosmetics, and medical products. The company offers a comprehensive range of services including formulation development, production in modern facilities adhering to quality standards (GMP, HACCP), packaging, labeling, and logistics. They support clients throughout the entire project execution process, providing options for private label and white label products.
Financials
The financial statement for 2025 has not yet been filed with the Financial Document Repository (past deadline).
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2024.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2016-04-19. Active
03 1240 4751 1111 0011 4835 3957
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
No public aid cases recorded in the last 10 years.
Tenders
No recorded participation in tenders.
Trademarks
Pharmbiopol holds 2 active trademarks registered with the Polish Patent Office. The first mark was filed in 2025.
| Mark | Protected until | |
|---|---|---|
| Famflow | May 27, 2035 | |
| Baby Bloom | Feb 6, 2035 |
Authorized Representatives
Manner of representation
In the case of a one-person management board, declarations on behalf of the company are made by the member of the management board. In the case of a multi-member management board, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Juliusz Janusz Chorąży (23) | 10 | $135.06 | 10% |
Krzysztof Chorąży (53) | 90 | $1,215.56 | 90% |
Krzysztof Chorąży and Juliusz Janusz Chorąży hold a combined 100% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Packland KielczykS.K.A. | $284,416.38 | pack.land | ||
| Vorwarts Pharmasp. z o.o. | $210,138.62 | vorwartspharma.pl | ||
| Food SectorP.S.A. | $180,336.24 | foodsector.pl | ||
| Simplex Marketingsp. z o.o. | $151,776.94 | simplexpl.com | ||
| BL Medicasp. z o.o. | $148,305.98 | blmedica.pl | ||
| NutrisleP.S.A. | $135,614.44 | nutrisle.com | ||
| Sabir Isp. z o.o. | $117,609.26 | sabir1.org.pl | ||
| Tomapolsp. z o.o. | $97,656.88 | tomapol.pl | ||
| Mimic Polandsp. z o.o. | $85,589.70 | mimic.com.pl | ||
| Toto Pharma Polandsp. z o.o. | $66,269.14 | totopharma.com |
Change history
| Date | Event | |
|---|---|---|
| 2024-10-17 | Address change (Ul. Władysława Bełzy 10, 35-602, Rzeszów → Ul. Ignacego Łukasiewicza 3, 35-604, Rzeszów) | |
| 2024-10-04 | Name change (Freakers → Pharmbiopol) | |
| 2024-10-04 | PKD change (Removed: 46.90.Z; Added: 10, 21, 46.1, 46.3, 46.45, 46.46.Z, 46.7, 71.20.A, 82.92.Z) | |
| 2016-04-05 | Entered in the register |
FAQ
Last updated: 2026-04-17